GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Belite Bio Inc (NAS:BLTE) » Definitions » Other Stockholders Equity

BLTE (Belite Bio) Other Stockholders Equity : $114.59 Mil (As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Belite Bio Other Stockholders Equity?

Belite Bio's Other Stockholders Equity for the quarter that ended in Jun. 2024 was $114.59 Mil.

Belite Bio's quarterly Other Stockholders Equity increased from Dec. 2023 ($0.00 Mil) to Mar. 2024 ($96.47 Mil) and increased from Mar. 2024 ($96.47 Mil) to Jun. 2024 ($114.59 Mil).

Belite Bio's annual Other Stockholders Equity increased from Dec. 2021 ($0.00 Mil) to Dec. 2022 ($0.00 Mil) but then declined from Dec. 2022 ($0.00 Mil) to Dec. 2023 ($0.00 Mil).

Belite Bio Other Stockholders Equity Historical Data

The historical data trend for Belite Bio's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Belite Bio Other Stockholders Equity Chart

Belite Bio Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
- - - -

Belite Bio Quarterly Data
Dec20 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 55.72 52.79 - 96.47 114.59

Belite Bio Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Belite Bio Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Belite Bio's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Belite Bio Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Belite Bio Inc (NAS:BLTE) » Definitions » Other Stockholders Equity
Comparable Companies
RXRX MNKD KNSA BCRX XNCR MIRM EQRX IRON VIR CLDX OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
D01:Germany
Address
12750 High Bluff Drive, Suite 475, San Diego, CA, USA, 92130
Website
https://www.belitebio.com
Belite Bio Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics targeting untreatable eye diseases involving retinal degeneration such as atrophic age-related macular degeneration and autosomal recessive Stargardt disease or STGD1, both of which progressively lead to permanent blindness, and metabolic diseases such as non-alcoholic fatty liver disease, or NAFLD, nonalcoholic steatohepatitis, or NASH, type 2 diabetes, or T2D, and gout.